EDAP TMS S.A. (EDAP) –
-
Form EFFECT EDAP TMS SA
-
Form F-3 EDAP TMS SA
-
EDAP TMS S.A. (EDAP) PT Raised to $19 at H.C. Wainwright
-
Form 20-F EDAP TMS SA For: Dec 31
-
Form 6-K EDAP TMS SA For: Mar 27
-
EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
-
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
-
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
-
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
-
Form 6-K EDAP TMS SA For: Mar 04
-
EDAP (EDAP) Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
-
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
-
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
-
Form SC 13G/A EDAP TMS SA Filed by: Soleus Capital Master Fund, L.P.
-
EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
-
EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
-
EDAP (EDAP) Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
-
Form 6-K EDAP TMS SA For: Jan 02
-
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
-
EDAP TMS S.A. (EDAP) Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer
-
EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer
-
Form 6-K EDAP TMS SA For: Dec 07
-
EDAP (EDAP) Appoints Lance Willsey, M.S., M.D. to Board of Directors
-
EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
-
EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology
-
EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference
-
EDAP TMS S.A. (EDAP) PT Lowered to $9 at Piper Sandler
-
EDAP TMS S.A. (EDAP) Misses Q3 EPS by 5c
-
Form 6-K EDAP TMS SA For: Nov 09
-
EDAP Announces Third Quarter 2023 Financial Results
-
EDAP to Present at the Jefferies London Healthcare Conference
-
Vuzix Issues a Retraction of its November 2, 2023 Press Release
-
Vuzix Announces Partnership with EDAP TMS to Supply Smart Glasses for its Focal One® Robotic High Intensity Focused Ultrasound Platform
-
EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023
-
EDAP to Present at Morgan Stanley Annual Global Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference
-
EDAP TMS S.A. (EDAP) PT Raised to $16 at Lake Street Capital Markets
-
EDAP TMS S.A. (EDAP) Misses Q2 EPS by 9c
-
Form 6-K EDAP TMS SA For: Jun 30
-
EDAP Announces Second Quarter 2023 Financial Results
-
EDAP TMS SA to Announce Second Quarter 2023 Financial Results on August 24, 2023
-
EDAP TMS S.A. (EDAP) PT Raised to $16 at Lake Street Capital Markets
-
EDAP (EDAP) Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound
-
EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer
-
EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer
-
Form 6-K EDAP TMS SA For: Jun 06
-
EDAP to Present at the Jefferies Healthcare Conference
-
EDAP TMS S.A. (EDAP) PT Raised to $16 at Lake Street Capital Markets
-
Form 6-K EDAP TMS SA For: May 17
-
EDAP TMS S.A. (EDAP) Misses Q1 EPS by 19c
-
EDAP Announces First Quarter 2023 Financial Results
Back to EDAP Stock Lookup
